Moleculin Biotech, Inc. Common Stock Shares Outstanding

Quick Answer

Moleculin Biotech, Inc. reported Common Stock Shares Outstanding of 3.20 million shares for the year ending 2025.

  • Moleculin Biotech, Inc. showed an increase of +2,267.1% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Moleculin Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2015 to 2025), Moleculin Biotech, Inc.'s Common Stock Shares Outstanding has declined by 52.0%.
  • Historical annual values: Fiscal year 2025: 3.20 million shares | Fiscal year 2024: 135,155 shares | Fiscal year 2023: 2.23 million shares | Fiscal year 2022: 1.91 million shares | Fiscal year 2021: 28.58 million shares | Fiscal year 2020: 11.54 million shares | Fiscal year 2019: 7.62 million shares | Fiscal year 2018: 28.53 million shares | Fiscal year 2017: 21.47 million shares | Fiscal year 2016: 12.16 million shares | Fiscal year 2015: 6.66 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: